Pharmacology Seminar Series: Peter Pertel, PhD, MPH "Assessing preclinical data before dosing humans for the first time"

Name: Pharmacology Seminar Series: Peter Pertel, PhD, MPH "Assessing preclinical data before dosing humans for the first time"
Start: 2024-03-25T15:00:00-05:00
End: 2024-03-25T16:00:00-05:00
Location: Ward Building, 5-230

Monday, March 25, 2024 | 3:00 PM - 4:00 PM CT

Ward Building, 5-230, 303 E. Chicago Avenue, Chicago, IL 60611 map it

Add to Calendar

Assessing preclinical data before dosing humans for the first time

The talk will discuss how one reviews pharmacodynamic, pharmacokinetic, and safety data to assess potential risks and benefits, a process that occurs before one decides to administer a medicinal product to humans for the first time. Included will be methods to mitigate potential risks in clinical studies. The talk will not discuss formulation or commercial issues.

Peter Pertel, PhD, MPH, Former head of translational medicine in respiratory and infectious diseases, Novartis Institute for BioMedical Research (NIBR)

Audience

Faculty/Staff
Student
Post Docs/Docs
Graduate Students

Contact

Melissa Daley
Email

Group

Department of Pharmacology Seminars

Pharmacology Seminar Series: Peter Pertel, PhD, MPH "Assessing preclinical data before dosing humans for the first time"

Audience

Contact

Group

Interest

Add Event To My Group